Diabetes Conferences | April 07-08, 2025 | Vancouver, Canada

Diabetes Conferences,Top Diabetes conference, Top Diabetes Mellitus Conferences, Diabetes diet Conferences, Diabetes ketoacidosis Conferences, Top Diabetic neuropathy Summit, Gestational Diabetes Congress

Renowned Speakers

Pedro A. Jose

The George Washington University USA

Helmy M. Siragy

University of Virginia Health System USA

Alexandra Lucas

University of Florida USA

Hiroaki Satoh

Juntendo University Japan

Luisa Mestroni

University of Colorado USA

Mehran Roxana

Mount Sinai University USA

Sarah X. Zhang

State University of New York USA

Yoshifumi Saisho

Keio University Japan

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Europe & UK

Euro Endocrinology 2025, Italy Euro Cancer 2024, Italy surgery-anaesthesia 2025, Switzerland Addiction Congress 2024, Switzerland

Asia Pacific & Middle East

Biodiesel 2024, UAE BIOTECH ASIA PACIFIC 2025, UAE Dentists 2025, UAE Soil Science 2024, UAE

Canada

Diabetes Meeting 2025, Canada AGING MEET 2025, Canada CAM 2024, Canada Food Security 2025, Canada

Diabetes Meeting 2025

About Conference

We are privileged to announce its “36^th International Congress on Prevention of Diabetes and Complications” which will be held on April 07-08, 2025 in Vancouver, Canada. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Diabetes conference to witness invaluable scientific discussions and contribute to future innovations in the field of Diabetes.

According to WHO, about 60 million people with diabetes in the European Region. About 10.3% of men and 9.6% of women aged 25 years and over. Worldwide, high blood glucose kills about 3.4 million people annually amongst 80% of these deaths occur in low- and middle-income countries, and almost half are people aged under 70 years. WHO projects diabetes deaths will double between 2005 and 2030. The overall risk of death among people with diabetes is at least double the risk of their peers without diabetes. Reflecting this imperative, Conference Series is all set to host diabetes conference this year which will provide the future leadership in this key area for global health.

Diabetes Meeting 2025 will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Diabetes which include: Advanced Technologies for Treatment of Diabetes, Emerging Focus in Diabetes Research, Diabetes Research in Clinical Practice, Computational Biology of Diabetes, Cell Therapy for Diabetes and its Complications, Genetics of Diabetes, Diabetes Management, Transplantation for Diabetes, Endocrinology Disorders and Treatment.

Young Research’s Awards at Diabetes Meeting 2025 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Diabetes Meeting 2025 young research forum.

Benefits:

Young Scientist Award recognition certificate and memento to the winners
Our conferences provide best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development.
Provide an opportunity for research interaction and established senior investigators across the globe in the field
Share the ideas with both eminent researchers and mentors.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Diabetes Meeting 2025 provides best platform to expand your network, where you can meet scientists, authorities and CROs from around the world. It’s your time to grab the opportunity to join Diabetes conferences for promoting your research article and to facilitate prestigious award in all categories. In this fame, we look forward for your contribution and astonishing dedication to make our conference more successful.

Sessions & Tracks

Track 01: Diabetes Complications

Diabetes complications arise from prolonged high blood sugar levels, affecting various organs and systems in the body. Common complications include cardiovascular diseases like heart attacks and strokes, due to damaged blood vessels. Neuropathy (nerve damage) can cause pain or loss of sensation, especially in the feet, increasing the risk of infections and amputations. Kidney damage (nephropathy) may lead to kidney failure, while retinopathy can cause vision loss or blindness. Uncontrolled diabetes also weakens the immune system, making infections more likely. Poor circulation may result in slow wound healing, particularly in the extremities. Managing blood sugar, along with regular check-ups, proper diet, and exercise, is essential to prevent or minimize these serious complications.

Track 02: Genetic Diabetes

Genetic diabetes, primarily referring to Type 1 and Type 2 diabetes, involves complex interactions between multiple genes and environmental factors. Type 1 diabetes is largely an autoimmune condition with strong genetic predispositions, linked to specific HLA gene variants. In contrast, Type 2 diabetes has a more polygenic nature, with several genes affecting insulin sensitivity and secretion. Research into genetic markers can help identify individuals at risk and enable personalized treatment approaches. Understanding these genetic factors also opens avenues for gene therapy and advanced preventive strategies, offering hope for more effective management of diabetes in the future.

Track 03: Diabetes Treatments

Diabetes treatments aim to manage blood sugar levels and prevent complications. For Type 1 diabetes, insulin therapy is essential, with various delivery methods like injections, pumps, or inhalers. Type 2 diabetes management may involve lifestyle changes such as diet and exercise, along with oral medications (e.g., metformin) and, in some cases, insulin. Newer therapies, like GLP-1 receptor agonists and SGLT2 inhibitors, help regulate blood sugar and offer cardiovascular benefits. Continuous glucose monitoring systems provide real-time data for better control. Emerging treatments, including smart insulin and gene therapy, show promise. Comprehensive diabetes management also includes regular health check-ups, education, and support to empower patients in maintaining optimal health.

Track 04: Diabetes Management

The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment. Healthy eating is a cornerstone of healthy living — with or without diabetes. But if you have diabetes, you need to know Impact of Food and Nutrition, impact of physical activity and yoga therapy in Diabetes Management. Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. Standards of medical care in Diabetes increased when compared to previous year.

Track 05: Innovations in Diabetes Education

Innovations in diabetes education focus on enhancing patient understanding and management of the condition. Digital platforms, including mobile apps and online courses, provide accessible resources for self-monitoring and personalized education. Interactive tools, such as virtual reality simulations, help patients visualize the impact of diet and exercise on blood glucose levels. Telehealth services facilitate remote consultations, allowing for continuous support and education from healthcare professionals. Furthermore, community-based programs emphasize peer support and real-life experiences, fostering a sense of shared learning. Research indicates that these innovative approaches improve health literacy and adherence to treatment plans, ultimately leading to better health outcomes for individuals living with diabetes. Effective education remains a cornerstone of comprehensive diabetes management.

Track 06: Gut Microbiome and Diabetes

The gut microbiome plays a crucial role in regulating metabolic processes and has emerged as a significant factor in the development of diabetes, particularly type 2 diabetes. The diverse community of bacteria in the gut influences glucose metabolism, insulin sensitivity, and inflammation. Dysbiosis, an imbalance in gut bacteria, can lead to increased intestinal permeability, allowing harmful substances to enter the bloodstream and trigger inflammatory responses that impair insulin action.
Research shows that individuals with type 2 diabetes often have reduced microbial diversity and specific bacterial populations linked to better metabolic health. Probiotics and dietary interventions, such as increasing fiber intake, can help restore a healthy microbiome and improve glycemic control. Furthermore, understanding the gut-brain axis and its connection to appetite regulation and energy expenditure may offer new therapeutic strategies for diabetes management. Overall, the gut microbiome represents a promising frontier in diabetes research and treatment.

Track 07: Diabetic clinical care and Prevention

Effective diabetic clinical care and prevention focus on individualized management strategies to maintain optimal blood glucose levels and prevent complications. Key components include regular monitoring of blood sugar, blood pressure, and cholesterol levels, alongside patient education on diet, exercise, and medication adherence.
Lifestyle modifications, such as adopting a balanced diet rich in whole grains, fruits, and vegetables, and engaging in regular physical activity, are vital for both prevention and management. Healthcare providers emphasize early intervention, screening high-risk populations, and implementing evidence-based guidelines to reduce the incidence of type 2 diabetes. Multidisciplinary approaches, involving dietitians, endocrinologists, and diabetes educators, enhance patient support and education. Additionally, ongoing research into pharmacotherapy and technological innovations, like continuous glucose monitoring, further aids in improving outcomes. A proactive approach can significantly reduce the burden of diabetes and enhance quality of life for individuals at risk or living with the condition.

Track 08: Diabetes and Mental Health

Diabetes and mental health are closely interconnected, as managing a chronic condition can significantly impact emotional well-being. Individuals with diabetes often experience higher rates of depression, anxiety, and stress, which can complicate disease management and lead to poorer health outcomes. The constant monitoring of blood glucose levels and lifestyle adjustments can be overwhelming, contributing to feelings of frustration and fatigue. Additionally, the stigma surrounding diabetes may exacerbate mental health challenges. Conversely, poor mental health can negatively affect diabetes management, leading to neglect of self-care routines and medication adherence. Integrated care approaches that address both physical and mental health are essential. Providing psychological support and resources can empower individuals with diabetes, helping them to navigate their condition more effectively and improve their overall quality of life.

Track 09: Risk Factors and Related Diseases of Diabetes

Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.

Track 10: Endocrinology: Disorders and Treatment

Endocrinology is the study of hormones and the treatment of hormone based diseases. The endocrine glands produce chemicals called hormones. These hormones are released into the blood stream and exert their action by stimulating other organs in the body. However, Clinical trials on endocrinology look at new ways to prevent, detect, or treat disease. The major endocrine glands are the thyroid, pancreas, parathyroid, adrenal, gonad and pituitary. The hormones from these glands regulate growth, metabolism, blood pressure, reproduction as well as many other necessary functions. Early Diagnosis and Treatment of Endocrine Disorders, written by a distinguished panel of clinical experts and research scientists, focuses on the early signs and symptoms of common endocrine diseases, surveys the clinical testing needed for a diagnosis, and concisely presents the best current recommendations for therapy. Paediatric endocrinology is a medical subspecialty that studies and treats conditions affecting physical growth and sexual development in children, as well as diabetes and other disorders of the endocrine (hormone) glands.

Track 11: Diabetes Mellitus Type 1

Type 1 diabetes mellitus is an autoimmune condition where the body’s immune system mistakenly attacks insulin-producing beta cells in the pancreas. This leads to little or no insulin production, resulting in elevated blood glucose levels. It typically develops in children, adolescents, or young adults, but can occur at any age. Symptoms include increased thirst, frequent urination, fatigue, and unexplained weight loss. Management requires lifelong insulin therapy, regular blood glucose monitoring, and a balanced diet. Patients must also be vigilant about preventing complications, such as hypoglycemia and long-term effects on eyes, kidneys, and nerves. Research continues to explore potential advancements, including artificial pancreas systems and immunotherapy, to improve management and outcomes for those living with Type 1 diabetes.

Track 12: Diabetes Mellitus Type 2

Type 2 diabetes mellitus is a chronic condition characterized by insulin resistance and impaired insulin secretion. It often develops in adults, although increasing rates are observed in children and adolescents due to rising obesity rates. Risk factors include genetics, sedentary lifestyle, and poor dietary habits. Symptoms may include increased thirst, frequent urination, fatigue, and blurred vision, but some individuals may remain asymptomatic. Management focuses on lifestyle changes, such as adopting a balanced diet, increasing physical activity, and maintaining a healthy weight. Medications, including oral hypoglycemics and insulin, may be prescribed as needed. Regular monitoring of blood glucose levels and screening for complications, such as cardiovascular disease and neuropathy, are essential. Early intervention can significantly improve outcomes and quality of life for those with Type 2 diabetes.

Track 13: Thyroid Disorders

Thyroid disorders encompass a range of conditions affecting the thyroid gland, which plays a crucial role in regulating metabolism, energy levels, and overall hormonal balance. The two primary types are hypothyroidism, where the gland produces insufficient hormones, leading to symptoms like fatigue, weight gain, and depression, and hyperthyroidism, characterized by excessive hormone production, causing symptoms such as anxiety, weight loss, and rapid heartbeat. Autoimmune diseases like Hashimoto's thyroiditis and Graves' disease are common causes of these disorders. Diagnosis typically involves blood tests to measure hormone levels and antibodies. Treatment varies based on the disorder; hypothyroidism is often managed with hormone replacement therapy, while hyperthyroidism may require medications, radioactive iodine, or surgery. Lifestyle factors, such as diet and stress, can influence thyroid health. Regular check-ups and awareness of symptoms are essential for early detection and effective management of thyroid disorders.

Track 14: Obesity and Metabolism for Diabetes

Obesity significantly impacts metabolism and is a key risk factor for type 2 diabetes. Excess body fat, particularly around the abdomen, can lead to insulin resistance, where the body’s cells become less responsive to insulin. This dysfunction disrupts glucose regulation, resulting in elevated blood sugar levels. Metabolism is the process by which the body converts food into energy, and obesity can alter metabolic pathways, affecting how the body utilizes fats and carbohydrates. Inflammatory markers released by adipose (fat) tissue can further exacerbate insulin resistance, creating a cycle that increases the risk of diabetes. Managing obesity through a balanced diet, regular physical activity, and lifestyle changes can improve metabolic health and lower diabetes risk. Weight loss, even a modest reduction, can enhance insulin sensitivity and improve glycemic control. Therefore, addressing obesity is crucial in preventing and managing diabetes, promoting overall health and metabolic function.

Track 15: Artificial Intelligence in Diabetes Management

Artificial Intelligence (AI) is transforming diabetes management by enhancing patient care and optimizing treatment strategies. AI algorithms analyze vast datasets from continuous glucose monitors and insulin pumps to provide real-time insights into blood sugar patterns. These technologies enable personalized recommendations, helping patients adjust their diets and medication effectively. Predictive analytics can forecast potential hypoglycemic events, allowing for proactive interventions. Additionally, AI-driven applications facilitate remote monitoring and telehealth consultations, making diabetes management more accessible. Machine learning models are also being developed to identify risk factors and improve early diagnosis. Overall, AI is poised to revolutionize diabetes care, improving outcomes and empowering patients to take control of their health.

Track 16: Continuous Glucose Monitoring (CGM) Technologies

Continuous Glucose Monitoring (CGM) technologies are revolutionizing diabetes management by providing real-time glucose level data. Unlike traditional methods, which rely on periodic fingerstick tests, CGMs use sensors inserted under the skin to track glucose levels continuously, delivering updates every few minutes. This allows patients to see how food, exercise, and medication affect their blood sugar in real time. Many CGM systems are integrated with smartphones and insulin pumps, enabling personalized alerts for high or low glucose levels. Research shows that CGM use can lead to improved glycemic control and reduced hypoglycemic episodes. As technology advances, CGMs are becoming more user-friendly and affordable, making them an essential tool for individuals with diabetes in managing their condition effectively.

Track 17: Diabetic Nephropathy

Diabetic nephropathy is a serious complication of diabetes characterized by kidney damage resulting from prolonged high blood sugar levels. It typically develops gradually, leading to proteinuria (excess protein in the urine) and reduced kidney function. Early detection is crucial, as it allows for interventions that can slow progression. Risk factors include poor glycemic control, hypertension, and genetic predisposition. Management strategies focus on controlling blood glucose levels and blood pressure, often using medications like ACE inhibitors or angiotensin receptor blockers. Lifestyle modifications, such as a balanced diet and regular exercise, also play a vital role. If left untreated, diabetic nephropathy can progress to end-stage renal disease, necessitating dialysis or kidney transplantation, significantly impacting quality of life.

Track 18: Dietary Patterns on Diabetes Control

Dietary patterns play a crucial role in managing diabetes and controlling blood sugar levels. A balanced diet rich in whole foods—such as fruits, vegetables, whole grains, lean proteins, and healthy fats—can significantly improve glycemic control. For instance, a diet high in fiber helps slow down glucose absorption, reducing spikes in blood sugar. Conversely, diets high in processed foods, sugars, and unhealthy fats can lead to insulin resistance and worsen diabetes management. The Mediterranean diet and plant-based diets have shown promise in enhancing metabolic health and reducing diabetes risk due to their anti-inflammatory properties and nutrient density. Portion control and regular meal timing also contribute to better blood sugar regulation. Additionally, staying hydrated and limiting sugary beverages can further support diabetes management. Overall, adopting healthy dietary patterns not only aids in controlling diabetes but also promotes overall well-being, reducing the risk of complications associated with the condition.

Track 19: Diabetes and Cardiovascular Risk

Diabetes significantly increases the risk of cardiovascular disease (CVD), making it a major concern for individuals with the condition. High blood sugar levels can damage blood vessels and nerves that control the heart, leading to issues such as hypertension, atherosclerosis, and heart attacks. Additionally, diabetes often coexists with other risk factors, including obesity, high cholesterol, and a sedentary lifestyle, further amplifying cardiovascular risk. Inflammation and oxidative stress associated with diabetes contribute to the development of heart disease. People with diabetes are more likely to experience endothelial dysfunction, which impairs blood flow and increases clotting risk. Managing blood sugar levels through diet, exercise, and medication is essential for reducing cardiovascular risk. Regular monitoring of blood pressure and cholesterol levels, along with lifestyle modifications, can also play a crucial role in heart health. Overall, a proactive approach to diabetes management is vital for minimizing cardiovascular complications and promoting long-term well-being.

Track 20: Diabetes in Adolescents

Diabetes in adolescents, particularly type 2 diabetes, has become increasingly prevalent due to rising obesity rates and sedentary lifestyles. This condition occurs when the body becomes resistant to insulin or fails to produce enough, leading to elevated blood sugar levels. Symptoms may include increased thirst, frequent urination, fatigue, and blurred vision. Managing diabetes in adolescents is crucial, as it can impact their growth, development, and overall quality of life. Effective management typically involves a combination of lifestyle changes—such as adopting a balanced diet, engaging in regular physical activity, and monitoring blood sugar levels—alongside possible medication. Psychosocial factors also play a significant role, as adolescents may struggle with the emotional burden of managing a chronic condition. Education and support from family, healthcare providers, and peers are essential for promoting healthy habits and fostering resilience. Early intervention and consistent management can help mitigate complications and improve long-term health outcomes.

Track 21: Diabetes and Pregnancy

Diabetes during pregnancy requires special management to protect the health of both mother and baby. There are two main types: pre-existing diabetes (Type 1 or Type 2) and gestational diabetes, which develops during pregnancy. Managing blood sugar levels is crucial, as high levels increase the risk of complications, including preeclampsia, high birth weight, and preterm birth. Treatment involves a balanced diet, regular exercise, and sometimes insulin or other medications. Frequent prenatal check-ups help monitor fetal development and blood sugar control. After delivery, women with gestational diabetes should be tested for Type 2 diabetes, as they’re at higher risk. With careful management, women with diabetes can have healthy pregnancies and outcomes.

Market Analysis

“36^th International Congress on Prevention of Diabetes and Complications which is going to be held on April 07-08, 2025 in Vancouver, Canada.

Diabetes Conferences 2025 invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes conference under a single roof where networking and global partnering happens for the acceleration of future research.
Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific
Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.
USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000
Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1
Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020
Diabetes is one of the fastest growing health challenges of the 21st century, with the number of adults living with diabetes having more than tripled over the past 20 years. In 2000, the global estimate of adults living with diabetes was 151 million. By 2009 it had grown by 88% to 285 million. Today, we calculate that 9.3% of adults aged 20–79 years – a staggering 463 million people – are living with diabetes. A further 1.1 million children and adolescents under the age of 20 live with type 1 diabetes. A decade ago, in 2010, the global projection for diabetes in 2025 was 438 million. With over five years still to go, that prediction has already been surpassed by 25 million will be 578 million adults with diabetes by 2030, and 700 million by 2045.
Type 1 diabetes is caused by an autoimmune reaction in which the body’s immune system attacks the insulin-producing beta cells of the pancreas. As a result, the body produces very little or no insulin.
Type 2 diabetes is the most common type of diabetes. Initially, hyperglycaemia (high blood glucose levels) is the result of the inability of the body’s cells to respond fully to insulin, a situation termed ‘insulin resistance’.
Gestational diabetes (GDM) is characterized by high blood glucose levels during pregnancy. It may occur at any time during pregnancy. Women who experience GDM face an increased risk of developing type 2 diabetes later in life. In addition, babies born to mothers with GDM also have a higher lifetime risk of obesity and developing type 2 diabetes themselves. This contributes to an intergenerational cycle of obesity and diabetes that seriously impacts the health of the entire population, and the generations to come.
Impaired glucose tolerance (IGT) is a condition of raised blood glucose levels above the normal range, but below the recommended diabetes diagnostic threshold. The terms ‘prediabetes’ and ‘non-diabetic hyperglycaemia’ are sometimes used as alternatives.
IGT is important because it:
Indicates a risk of developing type 2 diabetes in the future;
Denotes an already heightened risk of cardiovascular diseases;
Offers the opportunity for interventions that can lead to the prevention of type 2 diabetes. The estimated number of adults with IGT, and therefore at increased risk of developing type 2 diabetes, is 374 million. It is predicted to rise to 454 million by 2030 and to 548 million by 2045.
Insulin: Launch of generic versions of insulin and extensively growing demand for novel insulin in controlling the blood sugar levels in both type 1 and type 2 diabetes ate factors anticipated to fuel the growth of insulin segment in the market during the forecast period. In march 2019 Eli Lilly (key player) and company launched Lispro, a generic version of rapid-acting Humalog insulin which shall be available in the US by making it more accessible for diabetic patients. Additionally, growing investments in research and development by many government organizations and new product launches by many key players are like to boost the diabetes drugs market growth during the forecast period. For example, in 2019 Glenmark launched an oral anti-diabetic drug Remogliflozin in India which is considered as an effective drug treating adults with type-2 diabetes mellitus.
Growing urbanization and changing lifestyle habits (e.g. higher calorie intake, increasing consumption of processed foods, sedentary lifestyles) are contributory factors for the increasing prevalence of type 2 diabetes at a societal level. While global prevalence of diabetes in urban areas is 10.8%, in rural areas it is lower, at 7.2%. However, this gap is closing, with rural prevalence on the rise.
Diabetes increases the risk of early death: Approximately 4.2 million adults will die as a result of diabetes and its complications in 2019. This is equivalent to one death every eight seconds. Globally, 11.3% of deaths are due to diabetes. Almost half of these deaths are in people under 60 years of age. Half of the 463 million adults living with diabetes today are unaware that they have the condition, and are therefore at high risk of developing serious diabetes related complications.
Economic and social impact: Annual global health expenditure on diabetes is estimated to be at USD 760 billion under direct costs. It is projected that these direct costs will reach USD 825 billion by 2030 and USD 845 billion by 2045. The costs of treating complications account for over 50% of the direct health costs of diabetes. For example, management of diabetic ketoacidosis (DKA) is a considerable part of the cost to a country’s health system: treatment of a single DKA episode in the United Kingdom costs an estimated GBP 1,387 (around USD 1,750).

Age profile of diabetes

Working age (20-64) 72.0% three in four people living with diabetes (352 million people) are of working age (between 20 and 64 years old). This number is expected to increase to 417 million by 2030 and to 486 million by 2045.

Older people (65+) 27.8% in 2019, the estimated number of people over 65 years of age with diabetes is 111 million. One in five adults in this age group is estimated to have diabetes. It is projected that by 2030 the number of people over 65 with diabetes will further increase to 195 million. By 2045, it will reach 276 million.

Children and adolescents (0–19) 0.2% an estimated 1.1 million children and adolescents (aged under 20) have type 1 diabetes. There is some evidence that type 2 diabetes among children and adolescents is increasing in some countries.

Geographical profile

Age adjusted comparisons - Prevalence of diabetes in adults (20-79 years)

World

2045	9.6%
2030	9.2%
2019	8.3%

Europe

2045	7.8%
2030	7.3%
2019	6.3%

South & Central America

2045	9.9%
2030	9.5%
2019	8.5%

Middle East & North Africa

2045	13.9%
2030	13.3%
2019	12.2%

North America & Caribbean

2045	13.0%
2030	12.3%
2019	11.1%

Africa

2045	5.2%
2030	5.1%
2019	4.7%

South-East Asia

2045	12.6%
2030	12.2%
2019	11.3%

Western Pacific

2045	12.8%
2030	12.4%
2019	11.4%

Countries with the highest numbers of people with diabetes (2021) In 2021, the countries with the largest numbers of adults with diabetes are China, India and the United States of America, and are anticipated to remain so until 2030. It is projected that the number of people with diabetes in Pakistan will exceed that in the United States of America by 2045, moving the country to third place.

Rank	Country	No. of people with diabetes (millions)
1	China	116.4
2	India	77.0
3	USA	77.0
4	Pakistan	19.4
5	Brazil	16.8
6	Mexico	12.8
7	Indonesia	10.7
8	Germany	9.5
9	Egypt	8.9
10	Bangladesh	8.4

Low- and middle-income countries: The highest prevalence of diabetes in adults occurs in high-income countries, with an estimated 10.4% of the population having diabetes. The diabetes prevalence is 4% in low-income countries, and 9.5% in middle-income countries.

Improved education at the population-level, strong health systems, and effective policy frameworks are key to adequately address the primary risk factors of type 2 diabetes (such as poor eating habits, obesity and inadequate physical activity) and the high numbers of people living with undiagnosed diabetes

Societies Associated with Diabetes Research:

Spanish Diabetes Society (Spain)

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Association National Italian Diabetic Athletes

Italian Society of Diabetology

International Diabetes Federation- Italy

Primary Care Diabetes Society

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedical Diabetes Research

Immunology of Diabetes Society

American Association of Diabetes Educators

American Diabetes Association

The Asian Association for the Study of Diabetes

International Association of the Diabetes and Pregnancy Study Groups

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Canadian Diabetes Association

Diabetes Australia

Austrian Diabetes Association

Flemish Diabetes Association (Belgium

Association of Juvenile Diabetes (Brazil)

Canadian Diabetes Association

Juvenile Diabetes Foundation of Chile

Diabetological Colombian Federation

Croatian Diabetes Association

Union of Diabetics of Czech Republic

Estonian Diabetes Association

Finnish Diabetes Association

French Diabetics Association

German Diabetes Union

Hellenic Diabetes Association (Greece)

Hong Kong Diabetes Federation

Icelandic Diabetic Association

Diabetic Association of India

Diabetes Federation of Ireland

The Diabetes Association (Italy)

Japan Diabetes Society

Korean Diabetes Association

Lithuanian Diabetes Association

Luxembourg Diabetes Association

Maltese Diabetes Association (Malta)

Mexican Diabetes Federation

Netherlands Diabetes Association

Diabetes New Zealand

Norwegian Diabetes Association

Diabetes Philippines

Polish Diabetes Association

Diabetic Association of Portugal

Diabetic Society of Singapore

Diabetes South Africa

Swedish Diabetes Association

Swiss Diabetes Society

Diabetes UK

Why to attend

36^th International Congress on Prevention of Diabetes and Complications gives you an opportunity to broaden your thinking and knowledge by listening to ideas and theories and recent developments in Diabetes. Diabetes Meeting 2025 can give you a wonderful opportunity to meet and interact with fellow researchers, experts across the World. It also allows you to meet new people.

Benefits of attending:

1. Learn from Top Professionals all over the world.
2. be familiar with the latest trends and challenges within your sector.
3. Share your research with top professors and get instant answers to your queries.
4. Participate in panel discussion session including live Q&A

Diabetes Meeting 2025, will be a truly international event; we expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.

Benefits of Joining Conference:

Get your abstract published with DOI
Get Certified for your participation
Reduced Costs Affordability
Knock Down Geographical Barriers
Convenience from comfort of your own home or from work
They’re Archived: Ability to view events in the recording
Great resource for learning new career skillS
Learn from the Pros
Global exposure to your research
Make new connections
Significant time saving
Increased engagement
Wider Reach
More Engaging
Position yourself as the expert

Salient features

Keynote speeches and plenary talks by researchers all over the globe
Opportunity to meet globe expert’s in regenerative medical science
Posters, e-posters and video presentation by research community
International Certification by Organizing Committee
Publishing accepted abstracting International Journals
The study provides an in-depth analysis of the global Cardiology market

Target Audience

Diabetes Researchers
Diabetes Scientists
Diabetes Investors
Diabetes Societies
Directors of Laboratories
Universities
Industries
Investigators
Post-Doctoral Fellows
Research and Diagnostic Laboratories
Clinical Fellows
Medical Devices companies
Pharmaceutical Companies
Business Entrepreneurs.

Past Conference

We had a huge success with the completion of 35^th International Congress on Prevention of Diabetes and Complications which was held in May 23-24, 2024 in Zurich, Switzerland. The significance of the meeting was achieved due to the accumulation of all the related group of spectators of research scientists to share their Knowledge, Research work, Technologies, and furthermore trade of worldwide Information towards the correct crowd at ideal time. Congress has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community in the field of Diabetes.

The conference was organized around the theme “Explore the Latest Trends and Advances in Diabetes Management”. The congress entrenched a firm relation of future strategies in the field of Diabetes.

We would like to thank each and every participant of Diabetes Meeting 2023 to make this a huge success. And special thanks to media partners for the promotion of our event.

The Conference Series Nursing Conferences aim to bring together the prominent researchers’ academic scientists, and research scholars to exchange and share their experiences on all aspects of Nursing. It is conjointly a knowledge domain platform for researchers, practitioners and educators to gift and discuss the foremost recent advances, trends, and issues in addition as sensible challenges and solutions adopted in the fields of Diabetes.

We are glad to announce its “36^th International Congress on Prevention of Diabetes and Complications, going to be held during April 07-08, 2025 in Vancouver, Canada. We cordially welcome all the eminent Researchers, Scientists, and Professors to be part of this prestigious conference.

Bookmark your dates for “Diabetes Meeting 2025,” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.